Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

By A. Maisel, P. Krishnaswamy, R. Nowak, J. McCord, J. Hollander, P. Duc, T. Omland, A. Storrow, W. Abraham, A. Wu and 8 more. New England Journal of Medicine, 2002

3,133 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/3a220f28d076e62794ba70a0865713351b7205cf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. J. Cleland
3. Gerasimos Filippatos
4. L. Tavazzi
5. E. Braunwald
6. S. Anker
7. C. Yancy
8. M. Gheorghiade

In Surgery

1. P. Devarajan
2. E. Braunwald

Citations in the corpus

• [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. (2005, background): “Plasma B-type natriuretic peptide (BNP) is released from the cardiac ventricles in response to increased wall stretch and volume overload and has been used to exclude and/or identify congestive heart failure (CHF) in patients admitted, for dyspnoea, to the emergency department.(1,32) Decision cut po”
• State of the art: Using natriuretic peptide levels in clinical practice (2008, background): “If a large proportion of patients with acute breathlessness had values in the grey zone this could reduce the clinical utility of NP but, in practice, 75% of patients have values above or below these cut-off values [13,14,16,22].”
• Systolic and diastolic heart failure in the community. (2006, neutral): “Diabetes mellitus 206 (37) 111 (36) 95 (38) .”
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. (2005, background): “) The cost-effectiveness of the test suggest that a normal result should obviate the need for further cardiological tests such as in the first instance echocardiography as well as more expensive investigations.(33)”